GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » Pretax Margin %

OSE Immunotherapeutics (XPAR:OSE) Pretax Margin % : -1,297.81% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. OSE Immunotherapeutics's Pre-Tax Income for the six months ended in Dec. 2023 was €-11.28 Mil. OSE Immunotherapeutics's Revenue for the six months ended in Dec. 2023 was €0.87 Mil. Therefore, OSE Immunotherapeutics's pretax margin for the quarter that ended in Dec. 2023 was -1,297.81%.

The historical rank and industry rank for OSE Immunotherapeutics's Pretax Margin % or its related term are showing as below:

XPAR:OSE' s Pretax Margin % Range Over the Past 10 Years
Min: -139325   Med: -98.47   Max: 4593.21
Current: -1042.7


XPAR:OSE's Pretax Margin % is ranked worse than
74.34% of 1025 companies
in the Biotechnology industry
Industry Median: -154.52 vs XPAR:OSE: -1042.70

OSE Immunotherapeutics Pretax Margin % Historical Data

The historical data trend for OSE Immunotherapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Pretax Margin % Chart

OSE Immunotherapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.64 -184.74 -65.43 -98.47 -1,042.70

OSE Immunotherapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.46 -13.15 -705.63 -879.46 -1,297.81

Competitive Comparison of OSE Immunotherapeutics's Pretax Margin %

For the Biotechnology subindustry, OSE Immunotherapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OSE Immunotherapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OSE Immunotherapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where OSE Immunotherapeutics's Pretax Margin % falls into.



OSE Immunotherapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

OSE Immunotherapeutics's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-23.221/2.227
=-1,042.70 %

OSE Immunotherapeutics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-11.278/0.869
=-1,297.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OSE Immunotherapeutics  (XPAR:OSE) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


OSE Immunotherapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


OSE Immunotherapeutics (XPAR:OSE) Business Description

Traded in Other Exchanges
Address
22, Boulevard Benoni Goullin, Nantes, FRA, 44200
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics (XPAR:OSE) Headlines

No Headlines